Accretion Pharmaceuticals Fair Value
Fair Value Analysis Export
P/B Based Valuation
Asset-Based Valuation
ACCPL Fair Value Analysis — Data Sources & Coverage
Accretion Pharmaceuticals financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit Accretion Pharmaceuticals share price today.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
ACCPL vs Healthcare Sector Peers — P/E, P/B & Market Cap
Accretion Pharmaceuticals P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Auro Laboratories | AUROLAB | 91.49 | 3.91 | ₹165 |
| Sun Pharmaceutical | SUNPHARMA | 41.43 | 5.83 | ₹442,581 |
| Jeena Sikho Lifecare | JSLL | 40.38 | 23.07 | ₹7,944 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.